• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. BD POSIFLUSH¿ XS PRE-FILLED FLUSH SYRINGE NACL 0.9%; PRE-FILLED SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. BD POSIFLUSH¿ XS PRE-FILLED FLUSH SYRINGE NACL 0.9%; PRE-FILLED SYRINGE Back to Search Results
Catalog Number 306572
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Edema (1820)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the patient developed "oedema" in the ankles after the bd posiflush¿ xs pre-filled flush syringe nacl 0.9% had been used to "flush the line before and after each infusion".However, there was no medical intervention reported, and no further information regarding the patient's outcome has been received.As reported by the customer, "details: report received to advised oedema identified in patient ankles.No further information obtained on outcome of patients' condition.Product - 306572 pfs 0.9%p/flush xs saline 10ml st - use to flush line before and after each infusion.Batch:8242797.".
 
Event Description
It was reported that the patient developed "oedema" in the ankles after the bd posiflush¿ xs pre-filled flush syringe nacl 0.9% had been used to "flush the line before and after each infusion".However, there was no medical intervention reported, and no further information regarding the patient's outcome has been received.As reported by the customer, "details: report received to advised oedema identified in patient ankles.No further information obtained on outcome of patients' condition.Product: 306572 pfs 0.9%p/flush xs saline 10ml st - use to flush line before and after each infusion.Batch:8242797".
 
Manufacturer Narrative
H.6.Investigation summary: dhr: complaint trending review of the lot for this issue reveals this is the seventh complaint.The non-conformances were reviewed for this batch, and there was no record of non-conformance which could contribute to the complaint verbatim reported by the customer.No sample available.Conclusion(s): there is no evidence that posiflush syringe was responsible for this reaction.A potential contributory factor maybe other medicinal products in use or administered at the time the patient¿s port was flushed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH¿ XS PRE-FILLED FLUSH SYRINGE NACL 0.9%
Type of Device
PRE-FILLED SYRINGE
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
donore road
drogheda
MDR Report Key8387158
MDR Text Key137726093
Report Number9616657-2019-00132
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,other
Type of Report Initial,Followup
Report Date 03/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date08/31/2021
Device Catalogue Number306572
Device Lot Number8242797
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/15/2019
Initial Date FDA Received03/04/2019
Supplement Dates Manufacturer Received02/15/2019
Supplement Dates FDA Received03/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-